Research on Magnetically Targeted Drug Delivery System Based on Fullerene Derivatives

被引:0
|
作者
Wang, Ying [1 ]
Su, Li [2 ]
Li, Bing [1 ]
Jin, Ningning [1 ]
Lu, Riji [3 ]
Zhang, Jing [1 ]
机构
[1] Zhengzhou Univ, Sch Chem & Energy Engn, 100 Sci Rd, Zhengzhou, Henan, Peoples R China
[2] Zhengzhou Third Peoples Hosp Lab, 1 Caishi St, Zhengzhou, Henan, Peoples R China
[3] Wei An Packaging Prod Co Ltd, 50 Meters West Jiangpu Rd,Suzhou Ind Pk, Suzhou, Jiangsu, Peoples R China
来源
MATERIALS SCIENCE-MEDZIAGOTYRA | 2021年 / 27卷 / 04期
关键词
carboxyl-terminated fullerene pyrrolidine; iron oxide; magnetic targeting; doxorubicin; PHOTODYNAMIC THERAPY; CONTROLLED-RELEASE; NANOPARTICLES; DOXORUBICIN; C-60;
D O I
10.5755/j02.ms.24918
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
A carboxyl-terminated fullerene pyrrolidine derivative was synthesized by 1, 3-dipolar cycloaddition of imine ylide (FPCOOH). UV-Vis, FT-IR and MALDI-TOF respectively verified the effective synthesis of compounds. The compound (FPCOOH) was used as an intermediate, and then the hydrothermal chemical bonding method was used to load ferric oxide on the compound (FP-COOH). Its purpose was to form a magnetic targeting carrier system (FP-IONP-COOH). Then use the non-covalent method to combine FP-IONP-COOH with doxorubicin. The ultimate goal was to improve the side effects of doxorubicin. The solubility experiments showed that both FP-IONP-COOH and FP-IONP-COOH/DOX had good water solubility. The investigation of magnetism showed that FP-IONP-COOH has good magnetism. Finally, in vitro release experiments further verified the targeting of FP-IONP-COOH/DOX. The cumulative release of DOX at 48 h could be as high as 82 %, whereas the accumulated release of FP-IONP-COOH/DOX at 48 h was only 48 %, and was able to release for more than 120 h, its sustained release in vivo.
引用
收藏
页码:444 / 450
页数:7
相关论文
共 50 条
  • [1] Development of control system for magnetically targeted drug delivery
    Mishima, F.
    Fujimoto, S.
    Takeda, S.
    Izumi, Y.
    Nishijima, S.
    JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 2007, 310 (02) : 2883 - 2885
  • [2] Ex vivo investigation of magnetically targeted drug delivery system
    Yoshida, Y.
    Fukui, S.
    Fujimoto, S.
    Mishima, F.
    Takeda, S.
    Izumi, Y.
    Ohtani, S.
    Fujitani, Y.
    Nishijima, S.
    JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 2007, 310 (02) : 2880 - 2882
  • [3] Stiction Mitigation of Nanoparticles in Magnetically Targeted Drug Delivery System
    Chakrabarty, Pralay
    Roy, Siddhanta
    Paily, Roy P.
    IEEE TRANSACTIONS ON MAGNETICS, 2022, 58 (03)
  • [4] Ferritin-Based Supramolecular Assembly Drug Delivery System for Aminated Fullerene Derivatives to Enhance Tumor-Targeted Therapy
    Zhang, Baoli
    Yang, Libin
    Jin, Yiliang
    Lu, Yicheng
    Li, Jianru
    Tang, Guoheng
    Liu, Yang
    Huo, Jiawei
    Xu, Ran
    Wang, Chunru
    Yan, Xiyun
    Li, Jie
    Fan, Kelong
    ADVANCED SCIENCE, 2025, 12 (08)
  • [5] A study on magnetically targeted drug delivery system using superconducting magnet
    Nishijima, S.
    Mishima, F.
    Terada, T.
    Takeda, S.
    PHYSICA C-SUPERCONDUCTIVITY AND ITS APPLICATIONS, 2007, 463 : 1311 - 1314
  • [6] Development of magnetically targeted drug delivery system using superconducting magnet
    Takeda, Shin-ichi
    Mishima, Fumihito
    Fujimoto, Suketaka
    Izumi, Yoshinobu
    Nishijima, Shigehiro
    JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 2007, 311 (01) : 367 - 371
  • [7] Nanocarriers for Magnetically Actuated Targeted Drug Delivery
    Sant, Vrinda
    Wang, Liping
    Jang, Grace
    Ban, Deependra
    Seth, Jay
    Kazmi, Sami
    Patel, Nirav R.
    Yang, Qingqing
    Lee, Joon
    Janetanakit, Woraphong
    Wang, Shanshan
    Head, Brian
    Glinsky, Gennadi
    Lal, Ratnesh
    BIOPHYSICAL JOURNAL, 2019, 116 (03) : 33A - 33A
  • [8] Mathematical modelling of magnetically targeted drug delivery
    Grief, AD
    Richardson, G
    JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 2005, 293 (01) : 455 - 463
  • [9] Targeted Drug Delivery Based on Gold Nanoparticle Derivatives
    Gholipourmalekabadi, Mazaher
    Mobaraki, Mohammadmahdi
    Ghaffari, Maryam
    Zarebkohan, Amir
    Omrani, Vahid Fallah
    Urbanska, Aleksandra M.
    Seifalian, Alexander
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (20) : 2918 - 2929
  • [10] Research Progress of Disulfide Bond Based Tumor Microenvironment Targeted Drug Delivery System
    Ma, Weiran
    Wang, Xiaoying
    Zhang, Dongqi
    Mu, Xupeng
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2024, 19 : 7547 - 7566